532 related articles for article (PubMed ID: 24799619)
1. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
[TBL] [Abstract][Full Text] [Related]
2. Radiosynthesis and Preclinical Evaluation of an α
Krzyczmonik A; Keller T; López-Picón FR; Forsback S; Kirjavainen AK; Takkinen JS; Wasilewska A; Scheinin M; Haaparanta-Solin M; Sączewski F; Solin O
Mol Imaging Biol; 2019 Oct; 21(5):879-887. PubMed ID: 30710261
[TBL] [Abstract][Full Text] [Related]
3. ¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
Luoto P; Suilamo S; Oikonen V; Arponen E; Helin S; Herttuainen J; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Scheinin M; Virta J; Virtanen K; Volanen I; Roivainen A; Rinne JO
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1947-56. PubMed ID: 24838249
[TBL] [Abstract][Full Text] [Related]
4. Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.
Lehto J; Hirvonen MM; Johansson J; Kemppainen J; Luoto P; Naukkarinen T; Oikonen V; Arponen E; Rouru J; Sallinen J; Scheinin H; Vuorilehto L; Finnema SJ; Halldin C; Rinne JO; Scheinin M
Synapse; 2015 Mar; 69(3):172-81. PubMed ID: 25530024
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
Finnema SJ; Hughes ZA; Haaparanta-Solin M; Stepanov V; Nakao R; Varnäs K; Varrone A; Arponen E; Marjamäki P; Pohjanoksa K; Vuorilehto L; Babalola PA; Solin O; Grimwood S; Sallinen J; Farde L; Scheinin M; Halldin C
Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25522417
[TBL] [Abstract][Full Text] [Related]
6. Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.
Lehto J; Virta JR; Oikonen V; Roivainen A; Luoto P; Arponen E; Helin S; Hietamäki J; Holopainen A; Kailajärvi M; Peltonen JM; Rouru J; Sallinen J; Virtanen K; Volanen I; Scheinin M; Rinne JO
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):120-7. PubMed ID: 25201008
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
[TBL] [Abstract][Full Text] [Related]
9. Application of the PET ligand [
Shahid M; Rinne JO; Scheinin M; Virta J; Marjamäki P; Solin O; Arponen E; Sallinen J; Kuokkanen K; Rouru J
EJNMMI Res; 2020 Dec; 10(1):152. PubMed ID: 33296042
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
Sallinen J; Holappa J; Koivisto A; Kuokkanen K; Chapman H; Lehtimäki J; Piepponen P; Mijatovic J; Tanila H; Virtanen R; Sirviö J; Haapalinna A
Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):239-49. PubMed ID: 23718812
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
[TBL] [Abstract][Full Text] [Related]
12. Radiosynthesis and evaluation of new α1-adrenoceptor antagonists as PET radioligands for brain imaging.
Airaksinen AJ; Finnema SJ; Balle T; Varnäs K; Bang-Andersen B; Gulyás B; Farde L; Halldin C
Nucl Med Biol; 2013 Aug; 40(6):747-54. PubMed ID: 23810488
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of [11C]MK-912 as an alpha2-adrenergic receptor radioligand for PET studies.
Shiue C; Pleus RC; Shiue GG; Rysavy JA; Sunderland JJ; Cornish KG; Young SD; Bylund DB
Nucl Med Biol; 1998 Feb; 25(2):127-33. PubMed ID: 9468027
[TBL] [Abstract][Full Text] [Related]
14. Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070.
Lehto J; Scheinin A; Johansson J; Marjamäki P; Arponen E; Scheinin H; Scheinin M
Synapse; 2016 Feb; 70(2):57-65. PubMed ID: 26562363
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
Gao M; Mock BH; Hutchins GD; Zheng QH
Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of new C-11 labeled benzo-1,4-dioxane PET radiotracers for brain α2C adrenergic receptors.
Alluri S; Eisenberg SM; Grisanti LA; Tanner M; Volkow ND; Kim SW; Kil KE
Eur J Med Chem; 2022 Dec; 243():114764. PubMed ID: 36272201
[TBL] [Abstract][Full Text] [Related]
18. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology.
Hashimoto H; Kawamura K; Igarashi N; Takei M; Fujishiro T; Aihara Y; Shiomi S; Muto M; Ito T; Furutsuka K; Yamasaki T; Yui J; Xie L; Ono M; Hatori A; Nemoto K; Suhara T; Higuchi M; Zhang MR
J Nucl Med; 2014 Sep; 55(9):1532-8. PubMed ID: 24963128
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of carbon-11 and fluorine-18 labeled tracers for in vivo visualization of PDE10A.
Ooms M; Celen S; Koole M; Langlois X; Schmidt M; De Angelis M; Andrés JI; Verbruggen A; Van Laere K; Bormans G
Nucl Med Biol; 2014 Sep; 41(8):695-704. PubMed ID: 25002365
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and evaluation of [11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1.
Yanamoto K; Konno F; Odawara C; Yamasaki T; Kawamura K; Hatori A; Yui J; Wakizaka H; Nengaki N; Takei M; Zhang MR
Nucl Med Biol; 2010 Jul; 37(5):615-24. PubMed ID: 20610166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
